• Technology has 'vast impact' on pharma development
    Advanced sequencing technologies have had a significant impact on the pharma development process

Bioanalytical

Technology has 'vast impact' on pharma development

Jul 26 2010

Pharma development has been vastly impacted by the advent of technologies such as chromatography and mass spectrometry, according to a report from Companies and Markets.

The analyst notes the technologies - including chromatography, mass spectrometry, DNA amplification and microarrays - that have changed the way pharma firms develop new drugs.

"Advanced technological developments in microarrays, bioinformatics and similar tools have increased the scope of applications and services," the company asserts.

Technology also helped the Human Genome Project to achieve success and, in turn, become an important part of DNA-based research in its own right.

After 13 years of research, the project was completed in 2003 and, after sequencing the genome itself, has moved on to a phase of analysis expected to last for many years.

With the market maturing, Companies and Markets says that operators involved in the creation of the technology behind DNA sequencing are now focusing on meeting specific needs as a means of differentiating their offerings from competitors.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions

Events

Korea Lab 2024

Apr 23 2024 Kintex, South Korea

Korea Chem 2024

Apr 23 2024 Seoul, South Korea

AOCS Annual Meeting & Expo

Apr 28 2024 Montreal, Quebec, Canada

SETAC Europe

May 05 2024 Seville, Spain

ChemUK 2024

May 15 2024 Birmingham, UK

View all events